Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine.
The institutionalized population and staff in a centre for the mentally retarded were tested retrospectively, and 1.6% hepatitis Bs antigen and 0.6% hepatitis Be antigen carriers were found among persons with mental retardation. The 40 subjects, residents and staff, with most risk of acquiring hepatitis B were given vaccination. The immunogenicity of the H-B-Vax vaccine was followed up prospectively and, in 7.5% of the vaccinated persons, even re-vaccination gave an unsatisfactory result.
Mölsä
P K
PK
Paimio Settlement for the Mentally Handicapped, Naskarla, Finland.
D000328:Adult; D002353:Carrier State / Q000276:immunology*; D004495:Education of Persons with Intellectual Disabilities; D005260:Female; D005387:Finland; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control; D006512:Hepatitis B Core Antigens / Q000032:analysis*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D017325:Hepatitis B Vaccines; D006801:Humans; D007117:Immunization, Secondary; D008607:Intellectual Disability / Q000276:immunology*; D008297:Male; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000276:immunology*
D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines